The association between lipid-lowering drugs and circulating concentration of PCSK9

被引：3
|
作者：
Reiner, Zeljko [1 ]
机构：
[1] Univ Hosp Ctr Zagreb, Dept Internal Med, Zagreb, Croatia
来源：
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2019年 / 26卷 / 09期
关键词：
SUBTILISIN/KEXIN TYPE 9; CARDIOVASCULAR EVENTS; PREVENTION;
D O I：
10.1177/2047487319840179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：928 / 929
页数：2
相关论文
共 50 条
  • [1] Lipid-lowering drugs and PCSK9
    Millan Nunez-Cortes, Jesus
    Mostaza Prieto, Jose M.
    [J]. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2016, 28 : 9 - 13
  • [2] Lipid Lowering Therapy and Circulating PCSK9 Concentration
    Nozue, Tsuyoshi
    [J]. JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2017, 24 (09) : 895 - 907
  • [3] ASSOCIATION OF LP(A) CONCENTRATION WITH THE VARIABILITY IN THE LIPID-LOWERING RESPONSE OF PCSK9 INHIBITORS
    Marco Benedi, M. V.
    Perez Calahorra, S.
    Bea, A. M.
    Baila Rueda, L.
    Lamiquiz Moneo, I.
    Cenarro, A.
    Jarauta, E.
    Laclaustra, M.
    Civeira, F.
    [J]. ATHEROSCLEROSIS, 2018, 275 : E161 - E161
  • [4] PCSK9 antibodies: A new class of lipid-lowering drugs
    Gouni-Berthold, Ioanna
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2015, 18 : 21 - 27
  • [5] PCSK9 and lipid lowering drugs
    Guo, Yuan-Lin
    Zhang, Wei
    Li, Jian-Jun
    [J]. CLINICA CHIMICA ACTA, 2014, 437 : 66 - 71
  • [6] Rapid effects of different lipid-lowering drugs on PCSK9 in humans
    Liu, Jun
    Guo, Yuan-Lin
    Xu, Rui-Xia
    Li, Jian-Jun
    [J]. CLINICAL LIPIDOLOGY, 2013, 8 (05) : 519 - 524
  • [7] Impact of currently prescribed lipid-lowering drugs on plasma PCSK9 concentration: single or in combination study
    Zhang, Yan
    Liu, Jun
    Li, Sha
    Xu, Ruixia
    Sun, Jing
    Li, Jianjun
    [J]. CARDIOLOGY, 2014, 129 : 29 - 29
  • [8] Lipid-Lowering Agents Targets Beyond PCSK9
    Hegele, Robert A.
    Tsimikas, Sotirios
    [J]. CIRCULATION RESEARCH, 2019, 124 (03) : 386 - 404
  • [9] Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
    Ye-Xuan Cao
    Jing-Lu Jin
    Di Sun
    Hui-Hui Liu
    Yuan-Lin Guo
    Na-Qiong Wu
    Rui-Xia Xu
    Cheng-Gang Zhu
    Qian Dong
    Jing Sun
    Jian-Jun Li
    [J]. Journal of Translational Medicine, 17
  • [10] Circulating PCSK9 and cardiovascular events in FH patients with standard lipid-lowering therapy
    Cao, Ye-Xuan
    Jin, Jing-Lu
    Sun, Di
    Liu, Hui-Hui
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Xu, Rui-Xia
    Zhu, Cheng-Gang
    Dong, Qian
    Sun, Jing
    Li, Jian-Jun
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2019, 17 (01)
12345